Report Detail

Other Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM2683297
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Non-Surgical
      • 1.4.3 Surgical
    • 1.5 Market by Application
      • 1.5.1 Global Crohn’s Disease Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Crohn’s Disease Therapeutics Market Size
    • 2.2 Crohn’s Disease Therapeutics Growth Trends by Regions
      • 2.2.1 Crohn’s Disease Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Crohn’s Disease Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Crohn’s Disease Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Crohn’s Disease Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Crohn’s Disease Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Crohn’s Disease Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Crohn’s Disease Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Crohn’s Disease Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Crohn’s Disease Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 5.2 Crohn’s Disease Therapeutics Key Players in United States
    • 5.3 United States Crohn’s Disease Therapeutics Market Size by Type
    • 5.4 United States Crohn’s Disease Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 6.2 Crohn’s Disease Therapeutics Key Players in Europe
    • 6.3 Europe Crohn’s Disease Therapeutics Market Size by Type
    • 6.4 Europe Crohn’s Disease Therapeutics Market Size by Application

    7 China

    • 7.1 China Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 7.2 Crohn’s Disease Therapeutics Key Players in China
    • 7.3 China Crohn’s Disease Therapeutics Market Size by Type
    • 7.4 China Crohn’s Disease Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 8.2 Crohn’s Disease Therapeutics Key Players in Japan
    • 8.3 Japan Crohn’s Disease Therapeutics Market Size by Type
    • 8.4 Japan Crohn’s Disease Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 9.2 Crohn’s Disease Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Crohn’s Disease Therapeutics Market Size by Type
    • 9.4 Southeast Asia Crohn’s Disease Therapeutics Market Size by Application

    10 India

    • 10.1 India Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 10.2 Crohn’s Disease Therapeutics Key Players in India
    • 10.3 India Crohn’s Disease Therapeutics Market Size by Type
    • 10.4 India Crohn’s Disease Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Crohn’s Disease Therapeutics Market Size (2014-2019)
    • 11.2 Crohn’s Disease Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Crohn’s Disease Therapeutics Market Size by Type
    • 11.4 Central & South America Crohn’s Disease Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Johnson & Johnson Services Inc.
      • 12.1.1 Johnson & Johnson Services Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Crohn’s Disease Therapeutics Introduction
      • 12.1.4 Johnson & Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.1.5 Johnson & Johnson Services Inc. Recent Development
    • 12.2 Pfizer Inc.
      • 12.2.1 Pfizer Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Crohn’s Disease Therapeutics Introduction
      • 12.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.2.5 Pfizer Inc. Recent Development
    • 12.3 Allergan
      • 12.3.1 Allergan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Crohn’s Disease Therapeutics Introduction
      • 12.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.3.5 Allergan Recent Development
    • 12.4 AbbVie Inc.
      • 12.4.1 AbbVie Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Crohn’s Disease Therapeutics Introduction
      • 12.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.4.5 AbbVie Inc. Recent Development
    • 12.5 Takeda Pharmaceutical Company Limited
      • 12.5.1 Takeda Pharmaceutical Company Limited Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Crohn’s Disease Therapeutics Introduction
      • 12.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.5.5 Takeda Pharmaceutical Company Limited Recent Development
    • 12.6 Celgene Corporation
      • 12.6.1 Celgene Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Crohn’s Disease Therapeutics Introduction
      • 12.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.6.5 Celgene Corporation Recent Development
    • 12.7 Perrigo Company PLC
      • 12.7.1 Perrigo Company PLC Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Crohn’s Disease Therapeutics Introduction
      • 12.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.7.5 Perrigo Company PLC Recent Development
    • 12.8 Ferring B.V.
      • 12.8.1 Ferring B.V. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Crohn’s Disease Therapeutics Introduction
      • 12.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.8.5 Ferring B.V. Recent Development
    • 12.9 Salix Pharmaceuticals
      • 12.9.1 Salix Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Crohn’s Disease Therapeutics Introduction
      • 12.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.9.5 Salix Pharmaceuticals Recent Development
    • 12.10 Gilead Sciences Inc.
      • 12.10.1 Gilead Sciences Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Crohn’s Disease Therapeutics Introduction
      • 12.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2014-2019)
      • 12.10.5 Gilead Sciences Inc. Recent Development
    • 12.11 Genentech Inc.
    • 12.12 UCB India Private Limited.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
      Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
      In 2018, the global Crohn’s Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Crohn’s Disease Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Johnson & Johnson Services Inc.
      Pfizer Inc.
      Allergan
      AbbVie Inc.
      Takeda Pharmaceutical Company Limited
      Celgene Corporation
      Perrigo Company PLC
      Ferring B.V.
      Salix Pharmaceuticals
      Gilead Sciences Inc.
      Genentech Inc.
      UCB India Private Limited.

      Market segment by Type, the product can be split into
      Non-Surgical
      Surgical

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Crohn’s Disease Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Crohn’s Disease Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Crohn’s Disease Therapeutics . Industry analysis & Market Report on Crohn’s Disease Therapeutics is a syndicated market report, published as Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Crohn’s Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report